Fibroblast growth factor 2 (FGF2), which is a member of the FGF family, induces ovarian cancer cell invasion by the activation of the PI3K/Akt/mammalian target Of rapamycin (mTOR) and MAPK/extracellular signal-regulated kinase (ERK) signaling pathways. Here, MTOR is linked to ovarian carcinoma.